Islet Amyloid Polypeptide Market – Innovative Therapies for Diabetes and Metabolic Disorders
The Islet Amyloid Polypeptide (IAPP) market is a specialized segment of the pharmaceutical industry, providing innovative therapies for diabetes and metabolic disorders. IAPP is a peptide hormone co-secreted with insulin by pancreatic beta cells, playing a crucial role in glucose regulation and appetite control. With rising prevalence of type 2 diabetes, increasing research funding, and...
0 Comments 0 Shares 167 Views 0 Reviews